Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia
NCT ID: NCT03028194
Last Updated: 2017-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
442 participants
INTERVENTIONAL
2015-10-01
2016-12-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia
NCT01382732
Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in Ghana
NCT01108289
Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone
NCT01317225
Labor Induction in Preeclampsia High-risk Women
NCT05056467
Vaginal Progesterone Against a Second Attack of Antepartum Haemorrhage in Placenta Previa Women
NCT04725929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of 442 patients with preeclampsia/eclampsia were randomized to postpartum curettage (223) or no procedure (219). Systolic and diastolic blood pressure were recorded and analyzed at hours 6, 12, 24 and 48. Also, several laboratory values and diuresis were evaluated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Curettage
Postpartum uterine curettage performed immediately after delivery of the placenta.
Curettage
Postpartum uterine curettage with a sharp curette # 14 or #16, immediately after delivery of the placenta.
Placebo
No procedure performed after delivery of the placenta.
Placebo
No procedure after delivery of the placenta
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Curettage
Postpartum uterine curettage with a sharp curette # 14 or #16, immediately after delivery of the placenta.
Placebo
No procedure after delivery of the placenta
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Preeclampsia/eclampsia
Exclusion Criteria
* Renal disease
* Heart disease
* Liver disease
15 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saint Thomas Hospital, Panama
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Osvaldo A. Reyes T.
Head of the Research Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Osvaldo Reyes, MD
Role: STUDY_CHAIR
Saint Thomas Hospital, Panama
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint Thomas H
Panama City, Provincia de Panamá, Panama
Saint Thomas Maternity Hospital
Panama City, Provincia de Panamá, Panama
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MHST2014-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.